Cardiometabolic risk and vascular changes in rheumatic diseases

Rheumatol Int. 2026 May 19;46(6):93. doi: 10.1007/s00296-026-06129-w.ABSTRACTRheumatic diseases (RDs) are chronic immune-mediated disorders associated with disproportionately increased cardiovascular morbidity and mortality. Accelerated atherogenesis in these diseases is driven by persistent systemi

Y Yuliya Fedorchenko

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE): protocol for an international investigator-initiated, prospective, randomised, open, blinded endpoint assessment (PROBE) interventional multi-centre trial

Eur Stroke J. 2026 May 6;11(5):aakag022. doi: 10.1093/esj/aakag022.ABSTRACTBACKGROUND: Acute ischaemic stroke patients with atrial fibrillation (AF) are at high risk of suffering a recurrent stroke or other cardiovascular complications. It is uncertain whether early rhythm-control therapy is effecti

M Märit Jensen